Janus Henderson Group
NGNE icon

Janus Henderson Group’s Neurogene NGNE Stock Holding History

Janus Henderson Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-709,469
Closed -$29.8M – 2563
2024
Q3 		$29.8M Sell
709,469
-125,322
-15% -$4.86M 0.02% 501
2024
Q2 		$30.4M Buy
834,791
+21,438
+3% +$756K 0.02% 489
2024
Q1 		$41.4M Sell
813,353
-28,335
-3% -$946K 0.02% 429
2023
Q4 		$16.3M Buy
+841,688
New +$12.1M 0.01% 584
2020
Q2 		– Sell
-3,485
Closed -$793K – 1364
2020
Q1 		$793K Buy
3,485
+2,894
+490% +$595K ﹤0.01% 1130
2019
Q4 		$146K Buy
+591
New +$58.9K ﹤0.01% 1400

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group's NGNE Position: Q4 2024 in Review

Janus Henderson Group sold out of Neurogene (NGNE) in Q4 2024, closing a stake of 709,469 shares — an estimated $29.8M sold.

Janus Henderson Group first reported a position in NGNE in Q4 2019 and held it in 6 quarters. The position peaked at $41.4M in Q1 2024. 88 funds tracked by Wall St. Rank hold NGNE as of Q4 2024.

  • Janus Henderson Group reported no remaining Neurogene position as of Q4 2024 after selling out during the quarter.
  • Janus Henderson Group sold 709,469 Neurogene shares in Q4 2024, an estimated $29.8M.
  • Janus Henderson Group first reported a position in Neurogene in Q4 2019 and held it in 6 quarters.
  • Janus Henderson Group's Neurogene position peaked at $41.4M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Neurogene as of Q4 2024.

Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.